SCHEMBL7330236

SCHEMBL7330236

O=C(NCCN1CCCCC1)c1c[nH]c2ccccc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.67
ALDH1A1 P00352 2/20 0.63
CYP1A2 P05177 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C9 P11712 1/20 0.63
TSHR P16473 1/20 0.63
THPO P40225 1/20 0.63
PMP22 Q01453 1/20 0.62
HRH3 Q9Y5N1 2/20 0.61
KDM4E B2RXH2 3/20 0.58
LMNA P02545 1/20 0.58
MAPT P10636 1/20 0.58
HSD17B10 Q99714 2/20 0.57
DRD2 P14416 1/20 0.57
HTR4 Q13639 2/20 0.56
HTR1A P08908 1/20 0.55
HTR2A P28223 1/20 0.55
HTR2C P28335 1/20 0.55
DRD3 P35462 1/20 0.55
HPGD P15428 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20267059 0.88 HPGD (0.61) KMT2AALDH1A1KDM4ELMNAHSD17B10
SCHEMBL9662273 0.83 DRD2 (0.53) KMT2AALDH1A1LMNAMAPTDRD2
SCHEMBL24076757 0.82 GRIN2B (0.72) HTR4
Hydrochloric Acid SCHEMBL27396097 0.81 KMT2A (0.55) KMT2AALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL1413908 0.80 KMT2A (1.00) KMT2AALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL9653400 0.80 DRD2 (0.72) DRD2HTR1AHTR2AHTR2CDRD3
SCHEMBL4131797 0.79 DRD2 (0.56) KMT2AALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL7531492 0.78 CYP1A2 (0.62) KMT2AALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL1041116 0.78 TSHR (1.00) KMT2AALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL5487791 0.77 HDAC1 (0.58) KMT2AALDH1A1KDM4EDRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998409-A GASTROINTESTINAL DISORDERS; CARDIOVASCULAR DISORDERS; NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM PLC (GB) 1999-12-07 US disclosed
EP-0630376-B1 CONDENSED INDOLE DERIVATIVES AS 5-HT4-RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1999-06-02 EP disclosed
EP-0630376-A1 CONDENSED INDOLE DERIVATIVES AS 5HT 4?-RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-12-28 EP disclosed
WO-1993018036-A1 CONDENSED INDOLE DERIVATIVES AS 5HT4-RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-09-16 WO disclosed